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"Abstract: The C-3 substituted phenylazo derivatives of lawsone (2-hydroxy-l,4 p-naphthoquinone, IIl) were
synthesized and characterized. The X-ray crystal structure was determined for the ligand 3-(3’-methyl
phenylazo)lawsone. The copper complexes ofthese derivatives were found to possess 1:2 metal stoichiometry
and square planar geometries with intermolecular stackings, resulting in antiferromagnetic exchange
interactions. The in vitro activity of all the synthesized compounds was examined against human breast
cancer cell-line, MCF-7, which revealed enhanced activities for the metal complexes, the highest activity
being observed for the copper compound of 3-(3’-methyl phenylazo) lawsone.
Introduction:
Quinonoidal ligands when used as therapeutic agents can exercise their cytotoxic action
by various mechanisms which include redox cycling, arylation, intercalation, induction of DNA
strand breaks, generation of free radicals and alkylation via quinone methide formation ’2. The
ability of 1,4 naphthoquinone to produce ’oxidative stress’ by redox cycling and to act
preferentially as alkylating agents is well established3’4. The representative examples of this
class of compounds include well-known anticancer drugs of the anthracycline and naphthazarin
series5’6. Analogous ligands like plumbagin (I) and shikonin (II) are also attributed with
anticancer activity7’8. Recently it has been shown by Couladouros et al.
9 that the 1,4
naphthoquinones bearing at least one phenolic hydroxyl group are potent inhibitors of
topoisomerase enzymes. The ability of these ligands to complex divalent metal ions such as
+2 +2 +2 Zn Cu ,Mg parallels their topoisomerase inhibition property and is thought to be the
underlying mechanism of their anticancer activity.
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Lawsone (2-Hydoxy-l,4-naphthoquinone, III) is a monohydroxy naphthoquinone
10ab pigment of henna plant possessing various biological properties, including antitumor
ativity. It is also an effective chelator of divalent and trivalcnt metal ions due to its
juxtaposed phenolic hydroxyl and kcto groups. The C-3 substituted derivatives of lawsonc
are particularly important since substitution at this position has been known to modulate its
5a b 16 17 18 redox potential ’, liposolubility and the propensity of metal complcxation To the best
of our knowledge, the ability of the metal complexes of C-3 substituted lawsonc derivatives to
act as antitumor agents has so far not been examined. In the present report we describe
synthesis, structural characterization and in vitro anticancer activities of a series of C-3
substituted phenylazo derivatives of lawsone and their copper complexes against the human
breast cancr cell line MCF-7, which reveals enhanced antitumor activities for the metal
complexes.
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Materials and Methods:
All chemicals used in the syntheses of ligands and their metal complexes were ofAR grade while
solvents were distilled prior to their use. Lawsone (Sigma Chemicals), Toludines (Methyl Anilines)(Sisco
Research Laboratories), CuCI2.2H20 (Qualigens), sodium nitrite (S. D. Fine chemicals Ltd. ) and sodium
acetate (Merck) were used as supplied, except for the toluidines, which were purified further according to the
literature methods9.
Synthesis ofliands
Typically 0.3g (2.8 mmol) of the toluidine derivative was diazotised
2 using 0.19g (2.8 mmol) of
sodium nitrite and 2N HCI. The diazonium salt was then allowed to couple with 0.5g (2.8 mmol) of
lawsone in ethanol in the presence of excess sodium acetate at a temperature below 10C. The precipitated
orange-red coloured azo derivative was filtered, washed with cold water and ethanol and dried in vacuum. The
crystals suitable for the X-ray diffraction studies were grown by slow evaporation of the acetonitrile solution
ofHMPAL2.
O
O
3-(2’- methyl phenylazo lawsone (HMPAL 1); 3-(3’- methyl phenylazo ) lawsone (HMPAL2)
3-(4’- methyl phenylazo ) lawsone (HMPAL3)
Figure 1: Schematic representation of3-(methyl phenylazo)lawsones (HMPAL)
Synthesis ofCoooer Comtlexes
The copper complexes were synthesized by refluxing the methanolic solutions of the ligands and
copper chloride dihydrate in 2:1 molar ratio for 3 hours. The precipitated brown-red complexes were filtered,
washed with cold ethanol and dried in vacuum.
Instruments
Elemental analyses were carried out using HOSLI CHN analyser at University of Pune. The
molecular weights were determined by the Atmospheric Pressure Chemical Ionization Mass Spectroscopy
(APCI-MS) carded out on a Hewlett-Packard 5989B quadrapole instrument connected to an electrospray
59987A unit with an APCI accessory and automatic injection using Hewlett-Packard 1100 series auto-
sampler. Infrared spectra were recorded as KBr discs on a Mattson 3000 FTIR spectrophotometer. Proton
NMR spectra were recorded in CDCI3 on a Bruker AC 250 instrument operating at 250 MHz using CDCI3
also as an internal reference standard. Electronic spectra were recorded on a Genesis-2 UV-VIS
Spectrophotometer in the range 200-1100 nm. The magnetic susceptibility of the copper complexes were
measured at 300K on a Faraday balance having field strength of 7000 KG using Hg[Co(SCN)4] as calibrant.
Cycllic voltammetric measurements were made in DMF solvent on a Bioanalytical system BAS CV-27 with
XY-recorder using platinum disc as working electrode against SCE and platinum wire as an auxiliary
electrode with teraethyl ammmonium perchlorate (TEAP) as a supporting electrolyte.
X-ray c. stal structure determination
All the measurements were made on a Siemens R3m/v diffractometer with Mo-Kt radiation (0.7107
). The data were collected at 293K on an orange crystal of 3-(3’-methyl phenylazo) lawsone (HMPAL2),
H2 N2 03, having dimensions 0.35x 0.25x 0.25 mm. Full matrix least squares refinement of the setting
angles (1.97-25.01) yielded a monoelinic cell with a 6.930(2) ,, b 4.851(2) ,., c 20.782(8)
90.000,,1 95.38, y= 90.00, V--695.5(4) -3. For Z--2 and FW= 292.29, the calculated density was 1.396
mg/m. Based on the systematic absences, packing considerations, statistical analysis of the intensity
distribution and the solution refinement of the structure, the space group was determined to be P21 /n. The
structure refinement was done using SHELXL-93t. Ofthe 1334 reflections collected 1225 were unique (R
0,1012). Full matrix least squares refinements on F2, gave weighted and unweighted agreement factors of
R1=0.0487, WR2=0.1208 for I > 2t(I) and R=0.2160, wR2=0.1740 for all data. Refinement on F for all
reflections except for three with very negative F or flagged b the user for potential systematic errors,
weighted R-factors wR and all oodness of fit S are based on F .Conventional R-factor R are based on F,
with F set to zero for negative F. The observed criterion ofF > 2o(F2) is used only for calculating R factor
observed etc. and is not relevant to the choice of reflections for refinement. R-factors based on F are
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statistically about twice as large as those based on F, and R-factors based on all data will be even larger. The
molecule is distorted and occupies two semi-populated sites related by crystallographic inversion centres.
Many atoms coincide and it was necessary to apply bond length constraints. Refinement using TWIN routine
was unsuccessful confirming the distorted nature ofthe structure opposed to racemic twinning.
Anticancer activity assay
The breast tumor cell line, MCF-7, was maintained in RPMI culture medium (Gibco), containing penicillin
(50U/ml) streptomycin (50 mg/ml) amphoteracin (2 mg/ml) and 10% fetal calf serum (Gibco}. For
experiments, cells seeded into 48 well culture plates at densities between 2000 to 5000 cells per cm, were
kept at 37C in an atmosphere of 5% COz Test substances dissolved in DMSO (final concentration 0.1%)
were added to cells 24h ater seeding, and then cultures were maintained for a further 4 days. To determine
live cell numbers, the dye 3-[4,5-dimethylthiazol-2yl]-2,5-diphenyltetrazolium bromide (MTT, Sigma
Chemicals), a compound that is metabolized in the presence of the pyridine cofactors, NADH and NADPH,
to give blue insoluble crystals, was added to cells for 4h (final concentration, 0.1 mg/ml). Crystals formed
were then dissolved by the addition of a solution of sodium dodecyl sulphate (SDS) in HCI (final
concentration of 10% and 10 milimolar respectively). Following the overnight solubilization of the blue
crystals, colour intensity wa,s read at 550 nm and values were recorded as absorbance units. Previously using
this method, we have shown a good linear correlation between dye intensity and cell number2.
Results and discussion:
The analytical and spectroscopic data on the ligands and their copper complexes are
summarised in Table 1. Which clearly indicates that all copper complexes possess 1:2 metal to
ligand stoichiometry. A perspective view of the HMPAL2 structure is shown in Figure 2.
Figure 2. ORTEP plot ofHMPAL2
Lawsone, with its ortho-hydroxy group is known to exhibit keto / enol tautomerism.
Substitution at C-1 position have yielded essentially keto isomers as in case of 2-hydroxy-3-
methyl-l-thiosemicarbazone-l,4 naphthoquinone23. In the present compound the bond lengths
of C(2)-O(2) (1.36A) and C(4)-O(4) (1.26 A)confirm the existence of the keto form. The
C(5)-O(5) bond distance is observed to be same as that in case of 2-hydroxy-3-methyl-l,4-
naphthoquinone34. The elongated C(2)-O(2) bond is favourable for the intramolecular
hydrogen bonding with the N(1)nitrogen of the azo linkage. The bond length of N(1)-N(2)
linkage is characteristic of the azo form at least in the solid state
24 although azo / hydrazone
tautomerism has been noted earlier for this series of compounds by Padhye et al.25. Table 2
shows the selected bond lengths for HMPAL2 while Table 3 gives the comparative data on the
bond distances in related 1,4-naphthoquinones with C-3 substituted lawsone. It clearly indicates
that the present compound crystallizes in a 1,2-naphthoquinone compound rather than as a 1,4
naphthoquinone moiety from a polar solvent like acetonitrile.
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Table 1: Analytical data on the ligands and their copper complexes including electrochemistry,
Mass-s elemental
Compound Mass
pectral
ata
APCI-MS
(M+H)
+
HMPAL1 293
’HPAL2 ’293
netic moment and electronic s :tra.
Elementdl Ahalys Electronic El/2 in Volti
%C %H %M Spectra(nm) t300) BM
68.46 4.02 2i0, 255,
(69.86) (4.11) 429 438
68.8 4.04 207,258,426,
(69.86) (4.11) 450
[Cu(MPAL2)2] 646 467,530,62’3 1.58
-0.75",-
1.45 -1.55
-0.63" ,-
1.42 r,
-1.73
-0.70"- 1.26
-1.47
-1.17’,+0.32’
HIPAL3 ’293 68.64 4.02 210,258,426,
(69.86) (4.11) 447
[CU(MPAL1)2] 646 62.93 3.33 9.62 406,523,643 1.54
(63.20) (3.40)
(9.84)
63.10 3.49 9.69
(63.20) (3.40)
(9.84)
[Cu(MPAL3)2] 646 62.10 3.34 9.84 46i,563,632 1.56 -1.12r,+0.3T
(63.20) (3.40)
(9.84)
1.28r,+0.38
afiures in parenthesis are calculated values, CH3CN, tin Solid State as Nujol Mull,
n non.reversible, reversible.
Table 2" Inter-atomic distances (2) in HMPAL2
Distances.. (A),,
C(2)- 0(2) 1.36
C(5) ,0(5) 1.22
C(4) 0(4) 1.26
C(3) N(1) 1.36
N(1)- N(2) 1.37
N(2) cCIll)
1.54 C(13i- 17) ’1.48
C(1 ) C(10) 1.38
C(6)- C(7) 1.40
C(11)-C(16) 1.3’7
Table 3: Comparative data on bond distances of various l4-naphthoquinones
Compound Bond Distances (i) Reference
C(1)- O(1) C(2) -O(2) C(4) -0(4)
1.20 1’..’. 3 1.22 3 5 2-Hydroxy- 1,4-napht aoquinone
2-hydroxy-3-methyl- l4-naphthoquinone 1.22 1.36 1.22’ 36
2-hydroxy-3-chlor0-14-naphthoquinone 1.27 1.31’ 1.27 37
2-hydroxy-3-(3-methyl-2-butenyl)- ,4 1’.27 1.35 1.23’ ’3 8
naphthoquinone
2-hydroxy-3-(3’-methylphenyiazo)-l,4- 1.22 i.26’ 1.36’ ’Present’
naphthoquinone work.
a The numbering system adapted here is in accordance with the literature reports.
H NMR data for the ligands indicates the absence of a signal due to the olefinic proton
(5 6.36 ppm) at C-3 position in lawsone
26 confirming the substitution of the azo chromophore
at that position. A sharp singlet at 52.4 ppm is due to the methyl protons on the arylazo ring
while the multiplate observed at 57.8 ppm is typical of the benzenoid protons of the quinone
moiety27.
Table- 4 summarises the significant IR bands for the ligands and their metal complexes.
The IR spectra of the 3-phenyl azolawsone derivatives show a broad hydroxyl absorption
centred around 3400cm
1 due to intramolecular hydrogen bonding between C-4 hydroxyl group
and t- nitrogen of the azo linkage. This band is found to be absent in the copper compounds
indicating the replacement of the hydroxyl proton by the metal. The two absorption bands
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occurring at 1695-1700cm
1 and 1680-1684cm
"1 are typical of the 1,2-quinone carbonyl
absorptions-. These bands do not exhibit any appreciable shift upon complexation suggesting
that the carbonyls are not involved in metal comlexation. A medium absorption seen in all of
the ligands around 1695cm" is due to v(-C=N-) stretch arising out of the hydrazinic C(3)-N(1)
linkage due to tautomerization. The absence of this absorption in copper complexes confirms
such an assignment. A weak absorption found around 1420-1450 cm" is assigned to the
unsymmetrical stretches for the IR inactive v(-N=N-) linkage which is also observed in case of
trans-p-substituted azobenzenesTM and arylazo naphtholssb. These bands undergo a shift to
higher wavenumbers by 12-16cm" upon metal complexation suggesting the involvement of azo
nitrogen in chelation. However, it must be pointed out that these bands are quite weak being IR
inactive. The band appearing around 968 cm
1 associated with v(C-N=N-C) stretching
vibrations
z9 is found to appear at higher wavenumbers upon metal complexation. The
unaffected frequencies at 1590-1620cm’are assigned as the aromatic v(C=C) vibrations.
Table 4. Significant IR bands for lilands
Compound v(-OH) v(C=O)
HMPAL1
HMPAL2
HMPAL3
[Cu(MPAL1)|
[Cu(MPAL1)]
[Cu(MPAL1)|
* All values in era"
3400
3425
and their co
v(C=N)
3420 1680 1650 1700
1683 1650 1695
!684, 1650 1698
1685 1663
1682 1656
.! 681, 1666.
pper complexes.. *
v(-C-N=N-C-)
966
989
969
976
997
97’8
The ortho-hydroxynaphthoquinones are known to exhibit an intense quinonoid absorption
around 240-260 nm and a broad weak local excitation band around 420-430 nm respectively6.
The C-3 substituted phenylazo lawsone derivatives described presently show similar absorptions
with increased intensities for the band at 430-450 nm due to the extended conjugation. The
electronic spectra for the copper complexes show a weak intensity band around 500-600 nm
characteristic of dxy --->dz transition in a square planar copper environment 30a,.b. Similar
absorption has been noted in case of the square planar copper compound of 4,7-dimethyl-l,10-
phenanthroline3. The magnetic moments of the present copper compounds at 300K fall in
the range of 1.54-1.58 BM typical of square planar compounds undergoing antiferromagnetic
exchange interactions due to stacking arrangements. Similar intermolecular spin coupling
interactions have been observed by Pierpont et al.3- in case of many ortho-quinone metal
complexes. On the basis of the above structural data we would like to propose following
tentative structure for the present copper compounds (Figure 3).
The cyclic voltammetric profiles of the ligand HMPAL2 and its copper complex in DMF are
shown in Figure 4 as a representative example of the present class of compounds. The redox
potentials for other compounds are included in Table 1. It is observed that HMPAL2 ligand
exhibits three reduction peaks at 0.637, 1.425 and -1.737 Volts respectively corresponding
to the deprotonation, quinone to semiquinone and semiquinone to catechol conversion
processes according to Bodini et al.33 The latter two peaks are reversible while the former is
irreversible. On complexation the deprotonation peak is found to be absent confirming the
absence of hydroxyl group while the quinone to semiquinone peak is shifted to more positive
potentials viz. -1.275 Volts maintaining its reversibility. The Cu
+:/+ redox couple is observed
in case of the copper complexes, centred at +0.32 to +0.38V. The peak corresponding to the
semiquinone to catechol conversion is found to be absent in the copper complexes. The facile
one-electron redox cycles observed for the copper compounds are known to generate reactive
32hi b oxygen species (ROS) leading to cell damages ’.
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Figure 4. Cyclic voltammograms (100 mV/s) of a 10"aM solutions ot
(A) HMPAL2 (B) [Cu (MPAL2)2] in (with reversible copper peak resolved inside) DMF.
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R=CH3
Figure 3. Schematic representation of stacking of ligands in the copper complexes
All the compounds synthesized were tested on the human breast cancer cell line MCF-
7. The antiproliferative activities of the copper compounds were observed at appreciably lower
concentrations than their parent ligands (Figure 5)indicating that metal complexation with
copper clearly offers an advantage in designing more effective compounds against the
mammary turnouts. Amongst the compounds tested [Cu(MPAL2)2] shows the highest activity
indicating that the recta-substitution on the arylazo ring is important for modulating electronic
as well as steric parameters.
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0.4
0.3
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0
0 2 4 6 8 10
[compound] uglml
’
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I-MPAL2
I-.MPAL3
[Cu(MPAL)2]] = [Cu(MPAL2)2]
[Cu(MPAL3)2]
Figure 5. Cytot0xic effect of a series of’phenylazo lawsone derivative nd their copper
complexes.
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